{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:44:31Z","timestamp":1783637071233,"version":"3.55.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Over the past decade, several distinct novel renal epithelial neoplasms driven by underlying tuberous sclerosis comples (<jats:italic toggle=\"yes\">TSC)\/<\/jats:italic>mammalian target of rapamycin <jats:italic toggle=\"yes\">(MTOR)<\/jats:italic> pathway mutations have been described. We report herein two distinctive <jats:italic toggle=\"yes\">TSC2<\/jats:italic>-mutated renal cell carcinomas which do not fit any previously described entity. The two renal carcinomas occurred in young patients (ages 10 and 31\u00a0y), and were characterized by highly permeative growth within the kidney with metastases to perirenal lymph nodes. The neoplastic cells were predominantly large, multinucleated giant cells having variably eosinophilic to xanthomatous cytoplasm with basophilic stippling and frequent vacuolization. While the discohesive nature of the neoplastic cells, xanthomatous cytoplasm, immunoreactivity for histiocytic markers and minimal immunoreactivity for conventional epithelial markers raised the possibility of a histiocytic neoplasm, multifocal immunoreactivity for cytokeratin 20 helped establish their epithelial nature. Despite the aggressive growth pattern of these neoplasms and lymph node metastases, mitotic figures were rare and Ki-67 indices were low (&lt;1%). One patient with follow-up shows no evidence of disease seven years after nephrectomy with no adjuvant therapy. Next-generation sequencing demonstrated <jats:italic toggle=\"yes\">TSC2<\/jats:italic> mutations in each case. By immunohistochemistry, downstream markers of mTOR pathway activation S6K1, 4EBP1, and glycoprotein nonmetastatic melanoma protein B were all highly expressed in these neoplasms, suggesting mTOR pathway activation as the neoplastic driver. While the cytokeratin 20 immunoreactivity and focal basophilic cytoplasmic stippling suggest a relationship to eosinophilic solid and cystic renal cell carcinoma, and cytoplasmic vacuolization suggests a relationship to eosinophilic vacuolated tumor, these neoplasms appear to be distinctive given their permeative growth patterns and predominant xanthomatous giant cell morphology. Addition of cytokeratin 20 to a panel of epithelial markers helps avoid misdiagnosis in such cases.<\/jats:p>","DOI":"10.1097\/pas.0000000000001940","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:01:15Z","timestamp":1660017675000},"page":"1554-1561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Xanthomatous Giant Cell Renal Cell Carcinoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Pedram","family":"Argani","sequence":"first","affiliation":[{"name":"Departments of Pathology"},{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Oncology"},{"name":"Urology, The Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Pallavajjalla","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Haley","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tseh-Lin","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Royal Children\u2019s Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.W.","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Pathology, Royal Children\u2019s Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Lotan","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Oncology"},{"name":"Urology, The Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan School of Medicine, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41379-021-00971-y","article-title":"Renal cell carcinoma associated with tuberous sclerosis complex (TSC)\/mammalian target of rapamycin (MTOR) genetic alterations","volume":"35","author":"Argani","year":"2022","journal-title":"Mod Pathol"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"352","DOI":"10.6004\/jnccn.2017.7041","article-title":"Biallelic TSC2 mutations in a patient with chromophobe renal cell carcinoma showing extraordinary response to temsirolimus","volume":"16","author":"Maroto","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","article-title":"Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in pateints with metastatic renal cell carcinoma","volume":"22","author":"Kwiatkowski","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma. Clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"\u201cHigh-grade oncocytic renal tumor\u201d: morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Archiv"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7 positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41379-021-00896-6","article-title":"Germline or sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney","volume":"35","author":"Kapur","year":"2022","journal-title":"Mod Pathol"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41379-021-00906-7","article-title":"Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1","volume":"35","author":"Morini","year":"2022","journal-title":"Mod Pathol"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41379-021-00969-6","article-title":"Oncocytic renal neoplasms with diffuse cytokeratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway","volume":"35","author":"Mohanty","year":"2022","journal-title":"Mod Pathol"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-grade oncocytic tumor of kidney (CK7-Positive, CD117-Negative): incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Krasnov","year":"2021","journal-title":"Hum Pathol"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/modpathol.2014.105","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathologic, immunohistochemical, and molecular features supporting classification as a distinct entity","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\u201cRenal cell carcinoma with fibroleiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors. Supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/PAS.0000000000001530","article-title":"Acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) harbor recurrent mutations in KMT2C and TSC2 genes","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/leu.2016.63","article-title":"Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation","volume":"30","author":"Gondek","year":"2016","journal-title":"Leukemia"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000203","article-title":"t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","article-title":"Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification","volume":"35","author":"Nese","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of young people","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21)","volume":"26","author":"Argani","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin-K in neoplasms harbouring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod Pathol"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1309\/AJCPDTRTO2Z4UEXD","article-title":"Comprehensive Analysis of Cathepsin K Expression in Human Neoplasms","volume":"139","author":"Zheng","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R28-20250612","first-page":"505","article-title":"Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins","volume":"138","author":"Miettinen","year":"1991","journal-title":"Am J Pathol"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAI.0b013e31823605e7","article-title":"The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms","volume":"20","author":"Enriquez","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li","year":"2018","journal-title":"Histopathology"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.steroids.2017.10.013","article-title":"Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target","volume":"133","author":"Taya","year":"2018","journal-title":"Steroids"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and translocation-driven renal tumors","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:00:38Z","timestamp":1749747638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001940"}},"subtitle":["Another Morphologic Form of TSC-associated Renal Cell Carcinoma"],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001940","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}